Latest Product Commercialization News

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Talga Group has cemented its position in the European battery materials sector by securing full mining rights for its Nunasvaara South graphite mine and signing a binding supply agreement with fast-charging battery pioneer Nyobolt.

Nanoveu Limited has accelerated its commercial and technological momentum with a $3.02 million capital raise, a breakthrough 33% increase in drone flight time using its edge-AI chip, and progress toward a U.S. OTCQB listing.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

NoviqTech partners with HYDI to generate blockchain-backed carbon credits from hydrogen-on-demand diesel technology, aiming to reduce emissions and create new revenue streams.

Bioxyne Limited has upgraded its FY2025 revenue guidance to approximately $28 million, driven by strong domestic performance and significant progress in European and UK markets. The company also advances its psychedelic medicines pipeline, positioning itself for sustained growth.

Humm Group reported a solid 10% increase in assets under management to $5.3 billion for 3Q25, maintaining stable margins while advancing a new hybrid loan product and IT platform modernization.

EOS is midway through a strategic turnaround, divesting non-core assets and strengthening its balance sheet while advancing cutting-edge counter-drone, high energy laser weapons, and space control technologies amid robust global demand.

Arizona Lithium advances its Prairie Project with a pioneering commercial development plan for lithium brine extraction, regulatory approvals, and a $1.3 million capital raise to fund initial production.

Micro-X Ltd has secured a $5.6 million strategic partnership with Malaysian firm Billion Prima and raised $4 million in capital, marking a pivotal shift towards medical imaging while progressing key security and health technology projects.

REA Group has delivered a robust first half FY25 performance, posting a 20% revenue increase and a 26% rise in net profit, underpinned by strong Australian and Indian market growth. The company also announced a 26% higher interim dividend, signaling confidence in its ongoing momentum.